Report cover image

Hydrogels Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Publisher GlobalData
Published Nov 29, 2022
Length 170 Pages
SKU # GBDT17577148

Description

Hydrogels Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Summary

GlobalData's Medical Devices sector report, “Hydrogels Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Hydrogels pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Hydrogels includes dressings that consist of 96% water with a matrix of insoluble polymers embedded in it.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Hydrogels under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hydrogels and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hydrogels under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

170 Pages
  • About GlobalData
    • Hydrogels Overview
    • Hydrogels - Pipeline Products by Stage of Development
    • Hydrogels - Pipeline Products by Segment
    • Hydrogels - Pipeline Products by Territory
    • Hydrogels - Pipeline Products by Regulatory Path
    • Hydrogels - Pipeline Products by Estimated Approval Date
    • Hydrogels - Ongoing Clinical Trials
    • Hydrogels Companies - Pipeline Products by Stage of Development
    • Hydrogels - Companies Pipeline Products by Stage of Development
    • 3QMatrix, Inc. (Inactive) Company Overview
    • Abeona Therapeutics Inc Company Overview
    • AgeX Therapeutics Inc Company Overview
    • Alafair Biosciences Inc Company Overview
    • Albert Ludwigs University of Freiburg Company Overview
    • Amend Surgical, Inc. Company Overview
    • Angiotech Pharmaceuticals Inc Company Overview
    • BioCure Inc Company Overview
    • Biomendics LLC Company Overview
    • Brigham and Women's Hospital Company Overview
    • CelaCare Technologies LLC Company Overview
    • Ceramicos Para Aplicacoes Medicas SA Company Overview
    • Chi2Gel Ltd. Company Overview
    • CorMedix Inc Company Overview
    • Drexel University Company Overview
    • Edixomed Ltd Company Overview
    • Exogenus Therapeutics SA Company Overview
    • Flexion Therapeutics Inc Company Overview
    • Gel4Med Inc Company Overview
    • Gelesis Inc Company Overview
    • GelSana Therapeutics Inc Company Overview
    • HyperBranch Medical Technology Inc Company Overview
    • Icahn School of Medicine at Mount Sinai Company Overview
    • In2cure AB Company Overview
    • Institute of Nano Science and Technology Company Overview
    • Ionic Pharmaceuticals LLC Company Overview
    • IPI Singapore Company Overview
    • Jenarron Therapeutics Ltd Company Overview
    • Johns Hopkins University Company Overview
    • Kane Biotech Inc Company Overview
    • Keratin Biosciences Inc Company Overview
    • Magle Chemoswed AB Company Overview
    • Neotherix Ltd Company Overview
    • Northwestern University Company Overview
    • Novyx Technologies LLC Company Overview
    • O2 Regentech LLC Company Overview
    • Ohio State University Company Overview
    • Orla Protein Technologies Ltd Company Overview
    • Piramal Enterprises Ltd Company Overview
    • Plurogen Therapeutics Inc Company Overview
    • Queensland University of Technology Company Overview
    • Quick-Med Technologies Inc Company Overview
    • Regentys Corp Company Overview
    • Scarless Laboratories Inc Company Overview
    • Smith & Nephew Plc Company Overview
    • SolasCure Ltd Company Overview
    • Sonoma Pharmaceuticals Inc Company Overview
    • Spanish National Research Council Company Overview
    • Squid Healthcare Inc Company Overview
    • Stanford University Company Overview
    • SynDermix AG Company Overview
    • Syracuse Biolabs Inc Company Overview
    • Syracuse University Company Overview
    • Tectum Company Overview
    • Tel Aviv Sourasky Medical Center Company Overview
    • Tel Aviv University Company Overview
    • Texas Medical Center Company Overview
    • Tokyo University of Science Company Overview
    • University of California San Diego Company Overview
    • University of Florida Company Overview
    • University of Illinois at Chicago Company Overview
    • University of Queensland Company Overview
    • University of Wisconsin Madison Company Overview
    • Ventrix Inc Company Overview
    • VTT Technical Research Centre of Finland Ltd Company Overview
    • Washington University in St Louis Company Overview
    • Zeomedix, LLC Company Overview
    • Oct 27, 2022: ArcticZymes Technologies Q3 and first nine months 2022 results
    • Oct 27, 2022: Baxter International Reports Third-Quarter 2022 Results
    • Oct 21, 2022: ArcticZymes Technologies Announces Invitation to presentation of Q3 and first 9 months 2022 result
    • Sep 28, 2022: Covalon to Participate in the 12th International Pediatric Intestinal Failure and Rehabilitation Symposium in Toronto
    • Sep 26, 2022: Covalon to Showcase Infection Prevention Solutions at the Association for Vascular Access Annual Scientific Meeting
    • Sep 20, 2022: Piramal Enterprises Gains as BOD Approves 750 Crore Fundraising Plan
    • Sep 08, 2022: Robert G. Riney Named Henry Ford Health President and CEO
    • Sep 07, 2022: Baxter to Host Third-Quarter 2022 Financial Results Conference Call for Investors
    • Sep 01, 2022: Karl-Henrik Sundström appointed Chair of the Board of Mölnlycke
    • Aug 29, 2022: Covalon Announces Third Quarter Fiscal 2022 Results
    • Aug 17, 2022: First Watch Announces Retirement of Chairman Emeritus Ken Pendery, Jr.
    • Aug 11, 2022: Abeona Therapeutics Reports Second Quarter 2022 Financial Results
    • Aug 11, 2022: Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
    • Aug 08, 2022: InVivo Therapeutics Holdings Announces Quarterly Report For the quarterly period ended June 30, 2022
    • Aug 01, 2022: Advanced Medical Solutions Group Announce Directorate Change
    • Jul 29, 2022: Piramal Enterprises Announces Consolidated Results for Q1 FY2023
    • Jul 13, 2022: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results
    • Jul 07, 2022: Molnlycke will attend 22nd Annual Meeting of EPUAP
    • Jun 08, 2022: Baxter to Host Second-Quarter 2022 Financial Results Conference Call for Investors
    • Jun 08, 2022: Advanced Medical Solutions Grp Annual General Meeting
    • May 25, 2022: Baxter Highlights Business Strategies and Innovation at 2022 Investor Conference
    • May 12, 2022: NEXGEL Reports First Quarter 2022 Financial Results
    • May 12, 2022: Lineage Cell Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
    • May 10, 2022: Baxter to Host 2022 Investor Conference
    • May 09, 2022: NEXGEL to Report its First Quarter 2022 Financial and Operating Results on May 12, 2022
    • May 04, 2022: Piramal Enterprises Appointed Yesh Nadkarni As CEO Of Wholesale lending, in Piramal Capital & Housing Finance Limited (PCHFL)
    • Apr 28, 2022: NEXGEL to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022
    • Apr 28, 2022: Smith+Nephew First Quarter 2022 Trading Update
    • Apr 28, 2022: Piramal Enterprises plans to raise up to Rs 700 crore through bonds
    • Apr 06, 2022: Collegium Appoints Neil McFarlane to its Board of Directors
    • Apr 01, 2022: Piramal Enterprises appoints Axis Bank's ex-CEO Shikha Sharma as non-executive director
    • Mar 31, 2022: Abeona Therapeutics Announces Strategy Update and 2021 Financial Results
    • Mar 31, 2022: Smith & Nephew announces Directorate Change
    • Mar 30, 2022: ConvaTec Group announces Annual Report and Accounts 2021 and Notice of AGM
    • Mar 24, 2022: NEXGEL to Present at Maxim Group's 2022 Virtual Growth Conference
    • Mar 21, 2022: NEXGEL Reports Fourth Quarter and Full Year 2021 Financial Results
    • Mar 17, 2022: Nexgel to Report its Fourth Quarter and Full Year 2021 Financial and Operating Results on March 21, 2022
    • Mar 17, 2022: ConvaTec Group Announces Board Change
    • Mar 10, 2022: Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
    • Mar 08, 2022: ConvaTec Group Annual Results for the twelve months ended 31 December 2021
    • Mar 08, 2022: ConvaTec Group Announces Annual Results for the twelve months ended 31 December 2021
    • Mar 07, 2022: Smith & Nephew Announces Notice of Annual General Meeting
    • Mar 07, 2022: Smith & Nephew Notice of 85th Annual General Meeting
    • Feb 22, 2022: Smith+nephew Announces New Chief Executive Officer
    • Feb 10, 2022: Baxter to Present at Citi's 2022 Virtual Healthcare Conference
    • Feb 10, 2022: Piramal Enterprises announces consolidated results for Q3 & 9M FY2022
    • Feb 10, 2022: Piramal Enterprises Announces Report of the Auditors on Financial Results for the Quarter and Nine Months Ended 31st December, 2021
    • Jan 27, 2022: ConvaTec Group Announce Board Committee Changes
    • Jan 06, 2022: Baxter to Host Fourth-Quarter 2021 Financial Results Conference Call for Investors
    • Jan 04, 2022: NEXGEL to Present at HC Wainwright's Bioconnect Conference
    • Dec 22, 2021: Piramal Enterprises hires Rupen Jhaveri as group president
    • Dec 17, 2021: Piramal Enterprises Announces Resignation of Rajesh Laddha, ED & Group CFO
    • Dec 13, 2021: Covalon Announces Strong Year End and Fourth Quarter Results for Fiscal 2021
    • Dec 09, 2021: Convatec Announces Chief Financial Officer succession
    • Nov 15, 2021: Sonoma Pharmaceuticals Reports Second Quarter FY 2022 Financial Results
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.